article thumbnail

EU regulation lacks consideration of pharmaceutical industry emissions

E&T

The study has described the current regulation of pharmaceutical companies as being unable to prevent the release of chemicals into the environment throughout the manufacturing supply chain. Moreover, in the EU, it is not possible to refuse the marketing authorisation of human pharmaceuticals based on environmental reasons.

article thumbnail

Global Pharmaceutical Market Drives Innovative Digitalization to Accelerate Drug Discovery

Frost & Sullivan Manufacturing

June 16, 2022- Frost & Sullivan’s recent analysis, Global Pharmaceuticals Outlook , finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value chain. The global pharmaceuticals market, including small molecules and biologics, is expected to register 3.8%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2023 robot orders down 30% from 2022 in North America, according to A3

Robotics Business Review

The organization said it expects the slowdown, particularly in automotive manufacturing, to continue until the second half of 2024. economy, higher interest rates, and even the over-purchasing of robots in 2022 from supply chain concerns,” said Jeff Burnstein , president of A3, in a release. The Ann Arbor, Mich.-based

Robotics 102
article thumbnail

Cipher Pharmaceuticals announces appointment of new CFO

Canadian Manufacturing

OAKVILLE — Cipher Pharmaceuticals Inc. announced the appointment of senior finance executive Bryan Jacobs as Chief Financial Officer effective August 15, 2022. Craig Mull, Interim CEO commented on the appointment, “I am delighted to announce the addition of Mr. Jacobs to Cipher’s executive team.

article thumbnail

Health Canada grants production and distribution amended to Optimi Health for pharmaceutical manufacturing

Canadian Manufacturing

Health Canada grants production and distribution amended to Optimi Health for pharmaceutical manufacturing. The Company is scheduled to begin production and analytical testing of MDMA this October in its recently completed EU-GMP pharmaceutical manufacturing facility. VANCOUVER — Optimi Health Corp.,

article thumbnail

Willow to enter next phase of partnered pharmaceutical project

Canadian Manufacturing

a biotechnology company focused manufacturing sustainable functional ingredients announced a follow-on engagement with Sandhill One, LLC for the next phase in optimizing a proprietary enzyme vital to the development of a large volume Active Pharmaceutical Ingredient (API) used in nutraceutical and pharmaceutical products.

article thumbnail

Global manufacturing industry growth reached 3.8% in 2022

Control Engineering

Market Insights Machinery sector growth outperformed manufacturing in 2022. London, 31 st January 2023 – Updated research by Interact Analysis shows that Asia Pacific (APAC), Europe and the US have performed very differently in terms of manufacturing output growth during 2022. in 2022, compared to 3.3%